# A Local Register Study For Major Depression Of Paroxetine Controlled Release

> **NCT00368303** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 362 (—)

## Conditions studied

- Depressive Disorder, Major
- Major Depressive Disorder (MDD)

## Interventions

- **DRUG:** Paroxetine CR
- **DRUG:** Paroxetine IR

## Key facts

- **NCT ID:** NCT00368303
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 362 (—)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368303, "A Local Register Study For Major Depression Of Paroxetine Controlled Release". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00368303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*